Article

Mississippi to reimburse for TTT of wet AMD

Mountain View, CA-Add Mississippi to the list of states whose Medicare administrators will pay for transpupillary thermother-apy (TTT) treatment of wet age-related macular degeneration (AMD).

Related Videos
Image credit: Ophthalmology Times; Dean McGee Eye Institute resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
Vicki Chan, MD, shares pearls for leveraging the power of social media in health care
Related Content
FDA accepts new drug application for low-dose atropine from Sydnexis
March 11th 2025

FDA accepts new drug application for low-dose atropine from Sydnexis

Commercial real estate and your practice, part two with Colin Carr
May 21st 2022

Commercial real estate and your practice, part two with Colin Carr

AI and eye tracking: Technological companions to assess amblyopia in pediatric patients
March 3rd 2025

AI and eye tracking: Technological companions to assess amblyopia in pediatric patients

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)
May 12th 2022

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

Study highlights strong parental cooperation in preschool vision screening
February 14th 2025

Study highlights strong parental cooperation in preschool vision screening

Vyluma announces NMPA of China accepts drug application of NVK002 (low-dose atropine 0.01%) for myopia progression in children
January 30th 2025

Vyluma announces NMPA of China accepts drug application of NVK002 (low-dose atropine 0.01%) for myopia progression in children

© 2025 MJH Life Sciences

All rights reserved.